ArticleObesity surgery2020
Impact of Gastric Bypass on Erosive Esophagitis and Barret's Esophagus.
Article in Obesity surgery, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
17 citing papers in PubMed, 1 synthesis or guideline pooled it, 29 citations in OpenAlex.
- Barrett's Esophagus in Obese Patient Post-Roux-en-Y Gastric Bypass: a Systematic Review.Obesity surgery · 2022Pooled it
- International Federation for Surgery for Obesity and Metabolic Disorders Position Statement on the role of Upper Gastrointestinal Endoscopy Before and After Metabolic Bariatric Surgery.Obesity surgery · 2025Article
- Evaluation of Clinical Score, Esophageal Manometry and pH Monitoring before and after Conversion from Sleeve Gastrectomy to Roux-en-Y Gastric Bypass for Refractory Gastroesophageal Reflux Disease.Obesity surgery · 2025Article
- Antireflux Surgery in Patients with Moderate Obesity - Fundoplication or Roux-en-Y Gastric Bypass?Obesity surgery · 2025Article
- Impact of Sleeve Gastrectomy and Roux-en-Y Gastric Bypass on Esophageal Physiology and Gastroesophageal Reflux Disease: A Prospective Study.Obesity surgery · 2025Article
- The Impact of Tumor Stage and Histopathology on Survival Outcomes in Esophageal Cancer Patients over the Past Decade.Medical sciences (Basel, Switzerland) · 2024Article
- ADENOCARCINOMA AND DYSPLASIA IN BARRETT ESOPHAGUS: CRITICAL ANALYSIS OF RISK FACTORS AND SURVEILLANCE PROTOCOLS.Arquivos brasileiros de cirurgia digestiva : ABCD = Brazilian archives of digestive surgery · 2024Article
- Barrett`s Esophagus in Bariatric Surgery: Regression or Progression?Obesity surgery · 2023Article
- [Barrett's esophagus: histochemical difference between goblet cells and blue cells].Revista medica del Instituto Mexicano del Seguro Social · 2023Observational
- Y Not Roux-en-Y?: Resolution of Barrett's Esophagus After Surgical Conversion of Gastric Sleeve in Two Patients.Digestive diseases and sciences · 2023Article
- Turnkey algorithmic approach for the evaluation of gastroesophageal reflux disease after bariatric surgery.Gastroenterology report · 2023Review
- Management of gastric intestinal metaplasia in patients undergoing routine endoscopy before bariatric surgery.Updates in surgery · 2022Article
- Barrett's Oesophagus and Bariatric/Metabolic Surgery-IFSO 2020 Position Statement.Obesity surgery · 2021Article
- Gastroesophageal Reflux After Sleeve Gastrectomy.Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract · 2021Review
- Current Status and Issues Associated with Bariatric and Metabolic Surgeries in Japan.Obesity surgery · 2021Review
- Gastroesophageal Reflux Disease, Obesity, and Roux-en-Y Gastric Bypass: Complex Relationship-a Narrative Review.Obesity surgery · 2020Review
- Comments on Roux-en-Y Gastric Bypass as a Treatment for Barrett's Esophagus After Sleeve Gastrectomy.Obesity surgery · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe association between gastroesophageal reflux disease (GERD) and obesity is clearly defined. The incidence of erosive esophagitis (EE) and Barrett's esophagus (BE) are as high as 26 and 6%, respectively. Gastric bypass (GBP) is considered the gold standard for obese patients with GERD. Evidence about the impact of GBP on EE and BE is not yet clear but more inspiring every day.
methodsObese patients operated by GBP with EE or BE were included for this study. Demographics, BMI, %EWL, and the evolution of EE and BE with pre and postoperative upper endoscopy were analyzed.
resultsIn this study, 64 patients were included, 55 with EE and 9 with BE. The preoperative BMI was 44.29 km/m
conclusionPatients with EE had a statistically significant resolution after GBP. BE was improved or even resolved in many patients without acquiring significance but also without progression. Long-term surveillance data is necessary to define the certain evolution of EE and BE after GBP.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.